The antiviral activity of amixin, an interferon inducer, in experimental Western Nile Fever

Voprosy Virusologii

Volumn 49, Issue 2, 2004, Pages 8-11

  Loginova, S Ya ^a   Kovalchuk, A V ^a   Borisevich, C V ^a   Syromyatnikova, S I ^a   Borisevich, G V ^a   Pashchenko, Yu I ^a   Khamitov, R A ^a   Maximov, V A ^a   Schuster, A M ^a  

^a NONE

Author keywords

Amixin; Emergency prevention; Experimental infection; Interferon inducer; Mice; Prevention; Treatment; West Nile fever

Indexed keywords

AMIXIN; INTERFERON INDUCING AGENT; UNCLASSIFIED DRUG; ANTIVIRUS AGENT; INTERFERON; TILORONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; BRAIN TISSUE; DRUG EFFICACY; EXPERIMENTAL MODEL; INCUBATION TIME; INFECTION PREVENTION; LETHALITY; MOUSE; NONHUMAN; VIRUS INACTIVATION; VIRUS INFECTION; VIRUS INHIBITION; VIRUS REPLICATION; WEST NILE FLAVIVIRUS; ANIMAL; BLOOD; BRAIN; DISEASE MODEL; DRUG EFFECT; ISOLATION AND PURIFICATION; ORAL DRUG ADMINISTRATION; SUBCUTANEOUS DRUG ADMINISTRATION; VIROLOGY;

ANIMALIA; FLAVIVIRUS; WEST NILE VIRUS;

ADMINISTRATION, ORAL; ANIMALS; ANTIVIRAL AGENTS; BRAIN; DISEASE MODELS, ANIMAL; INJECTIONS, SUBCUTANEOUS; INTERFERONS; MICE; TILORONE; WEST NILE FEVER; WEST NILE VIRUS;

EID: 3242876089     PISSN: 05074088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Anderson J. F., Andreadis T. G., Vossbrinck C. R. et al. Isolation of West Nile virus from mosquitoes, crows, and a cooper's hawk in Connecticut // Science. - 1999. - Vol. 286. - P. 2331-2333.
2. Anderson J. F., Rahal J. J. Efficacy of Interferon alpha-2b and ribavirin against West Nile virus in vitro // Emerg. Infect. Dis. - 2002. - Vol. 8, N 1. - P. 107-108.
3. Giladi M., Metzkor-Cotter E., Martin D. A. et al. West Nile encephalitis in Israel, 1999: the New York connection // Emerg. Infect. Dis. - 2001. - Vol. 7, N 4. - P. 659-661.
4. Hubalek Z., Halouzca J. West Nile fever - a reemerging mosquito-born viral disease in Europe // Emerg. Infect. Dis. - 1999. - Vol. 5, N 5. - P. 643-650.
5. Jordan I., Briese T., Fisher N. et al. Ribavirin inhibits West Nile virus replication and cytopathic effect in neural cells // J. Infect. Dis. - 2000. - Vol. 182. - P. 1214-1217.
6. Lanciotti R. S., Roehrig J. T., Deubel V. et al. Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States // Science. - 1999. - Vol. 286. - P. 2333-2337.
7. Mugrue M., Murri S., Zientara S. et al. West Nile outbreak in horses in southern France, 2000: the return after 35 years // Emerg. Infect. Dis. - 2001. - Vol. 7, N 4. - P. 692-696.
8. Odelola H. A. Antiviral activity of Virazole on replication of viruses isolated in Nigeria // Current Chemotherapy / Eds W. Siegenthaler, R. Lathy. - Washington, 1978. - Vol. 1. - P. 3343-3345.
9. Petersen L. R., Roehrig J. T. West Nile virus: a reemerging global pathogen // Emerg. Infect. Dis. - 2001. - Vol. 7, N 4. - P. 611-614.
10. Shahar A., Lustig S., Akov Y. et al. Different pathogenicity of encephalitic togaviruses in organotypic cultures of spinal cord slices // J. Neurosci. Res. - 1990. - Vol. 25. - P. 345-352.
11. Shimoni Z., Niven V. J., Pitlick S., Bulvic S. Treatment of West Nile virus encephalitis with intravenous immunoglobulin // Emerg. Infect. Dis. - 2001. - Vol. 7, N 4. - P. 759.
12. Tsai T. F., Popovici F., Cernescu C. et al. West Nile encephalitis epidemic in southeastern Romania // Lancet. - 1998. - Vol. 352. - P. 767-771.
13. Weinberger M., Pitlik S. D., Gandacu D. et al. West Nile fever outbreak, Israel, 2000 // Emerg. Infect. Dis. - 2001. - Vol. 7, N 4. - P. 686-691.
14. Weiss D., Carr D., Kellachan J. et al. Clinical findings of West Nile virus infection in hospitalized patients, New York and New Jersey, 2000 // Emerg. Infect. Dis. - 2001. - Vol. 7, N 4. - P. 654-658.